Clinical Trial Update: A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the effects of celecoxib versus naproxen on blood pressure in pediatric arthritis patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis Juvenile Rheumatoid
• Juvenile Idiopathic Arthritis

Drugs mentioned

• Celecoxib (Celecoxib)
• Naprosyn / Naproxen (naproxen)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Arthritis, Juvenile Rheumatoid | Phase 4 | Status: COMPLETED | Results posted: 2015-11-11